Scientists have discovered that Pfizer’s COVID-19 vaccine may increase the risk of eye damage, leading to vision loss. The new study specifically…
Read More »Pfizer
BofA analyst Tim Anderson notes Pfizer (PFE) announced danuglipron, an oral GLP-1 obesity, is being discontinued, following a case of…
Read More »This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma…
Read More »Pfizer (PFE) reported fourth quarter and full-year 2024 earnings results Tuesday, narrowly beating Wall Street expectations and its stock remained…
Read More »(Reuters) -U.S. drugmaker Pfizer (PFE) beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by strong sales of its…
Read More »